Stockreport

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business rev [Read more]